VIRIDIAN THERAPEUTICS INC VRDN

US Healthcare Pharmaceutical Preparations
$19.40
+5.0%
52w: $13.30 – $33.78

Latest 13F among current holders filed 31 days ago (Jun 3, 2026)

Price — last 12 months

research preview data
13.3023.5433.78
Jun 20, 2025 Jul 2, 2026
Institutional holders
226
-4 QoQ
13F value
$2.21B
-34.0% QoQ
Smart-money holders
32
signal tier ≥ 2
New smart buyers
4
Q1 2026
Options barometer
0.7×
$6.0M calls / $8.8M puts

Institutional value by quarter

$1.29B
Q1 2024
$907.8M
Q2 2024
$1.99B
Q3 2024
$1.75B
Q4 2024
$1.23B
Q1 2025
$1.33B
Q2 2025
$2.02B
Q3 2025
$3.36B
Q4 2025
$2.21B
Q1 2026

Number of holders

138
Q1 2024
140
Q2 2024
167
Q3 2024
181
Q4 2024
179
Q1 2025
173
Q2 2025
170
Q3 2025
230
Q4 2025
226
Q1 2026

Who owns VRDN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
FMR LLC Long only active15.4M$300.8M0.0%+6.9%
BlackRock, Inc. Index provider7.8M$153.2M0.0%+21.8%
Bellevue Group AG ★2Fundamental diversified6.7M$131.6M3.1%+54.3%
STATE STREET CORP Index provider4.7M$91.4M0.0%+34.8%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical4.2M$81.5M0.0%
Fairmount Funds Management LLC ★3Fundamental concentrated3.9M$76.6M5.5%Held
Venrock Adviser, LLC ★3Fundamental concentrated3.9M$75.9M2.8%Held
PRICE T ROWE ASSOCIATES INC /MD/ Diversified mechanical3.2M$62.7M0.0%-6.8%
Paradigm Biocapital Advisors LP ★2Fundamental concentrated3.1M$61.6M1.3%+118.2%
WELLINGTON MANAGEMENT GROUP LLP Long only active3.1M$60.2M0.0%+56.2%
Kynam Capital Management, LP ★3Fundamental concentrated2.3M$45.8M2.9%+59.2%
GEODE CAPITAL MANAGEMENT, LLC Index provider2.3M$45.6M0.0%+17.1%
CITADEL ADVISORS LLC Multistrat pod2.3M$45.3M0.0%+241.1%
Balyasny Asset Management L.P. Multistrat pod2.3M$45.3M0.1%+359.6%
ALLIANCEBERNSTEIN L.P. Long only active1.4M$43.3M0.0%-1.6%
NOVO HOLDINGS A/S ★3Fundamental concentrated2.0M$39.1M3.2%-16.0%
BAKER BROS. ADVISORS LP ★2Fundamental diversified2.0M$38.6M0.2%Held
TANG CAPITAL MANAGEMENT LLC ★2Fundamental diversified1.8M$35.1M1.8%Held
Fisher Asset Management, LLC Long only active1.8M$34.6M0.0%-0.7%
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical1.6M$32.1M0.0%
GOLDMAN SACHS GROUP INC Bank broker1.6M$31.1M0.0%+25.9%
Avoro Capital Advisors LLC ★3Fundamental concentrated1.5M$29.3M0.3%Held
Deep Track Capital, LP ★2Fundamental diversified1.4M$27.3M0.6%-44.8%
D. E. Shaw & Co., Inc. Quant stat arb1.3M$24.7M0.0%+26.2%
PERCEPTIVE ADVISORS LLC ★2Fundamental diversified1.2M$22.9M0.5%-61.5%
BANK OF AMERICA CORP /DE/ Bank broker1.2M$22.8M0.0%+17.5%
DEUTSCHE BANK AG\ Bank broker1.0M$20.2M0.0%+115.2%
JPMORGAN CHASE & CO Bank broker1.1M$19.6M0.0%+4.9%
ADAGE CAPITAL PARTNERS GP, L.L.C. Other970.0K$19.0M0.0%+22.8%
LOOMIS SAYLES & CO L P Other927.7K$18.1M0.0%-37.4%
First Turn Management, LLC ★2Fundamental diversified911.3K$17.8M2.0%+32.0%
RICE HALL JAMES & ASSOCIATES, LLC Other898.6K$17.6M1.0%+1.6%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Bank broker888.3K$17.4M0.0%+537.4%
MORGAN STANLEY Bank broker870.2K$17.0M0.0%-49.9%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider727.9K$14.2M0.0%-2.8%
Eversept Partners, LP ★2Fundamental diversified713.3K$14.0M0.9%-60.0%
Candriam S.C.A. Other711.7K$13.9M0.1%-9.3%
MetLife Investment Management, LLC Insurance708.5K$13.9M0.1%+1510.8%
Woodline Partners LP Other700.9K$13.7M0.1%-37.2%
NORTHERN TRUST CORP Index provider697.0K$13.6M0.0%+4.3%
FEDERATED HERMES, INC. Diversified mechanical669.0K$13.1M0.0%+60.7%
MPM BIOIMPACT LLC ★2Fundamental concentrated649.9K$12.7M1.0%New
Nuveen, LLC Diversified mechanical604.9K$11.8M0.0%-18.5%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical591.2K$11.6M0.0%
ALGERT GLOBAL LLC Diversified mechanical564.0K$11.0M0.2%+32.7%
Parkman Healthcare Partners LLC Other557.9K$10.9M1.1%-29.2%
Elmind Capital, LP ★3Fundamental concentrated534.9K$10.5M3.0%-37.7%
DIMENSIONAL FUND ADVISORS LP Quant stat arb529.8K$10.4M0.0%-4.6%
ExodusPoint Capital Management, LP Multistrat pod330.4K$6.5M0.1%+256.4%
Point72 Asset Management, L.P. Multistrat pod322.8K$6.3M0.0%+27.0%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.